Praveen Kumar K S

Dr. Praveen Kumar K S

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Pregnancy Hypertension
Verified
Journal Article
Closed access
URUsha Rani
Usha Rani
PSPraveen Kumar K S
Praveen Kumar K S
MMMunikrishna Munisamaiah
Munikrishna Munisamaiah
DRDeepa Rajesh
Deepa Rajesh
SBSharath Balakrishna
Sharath Balakrishna

1 May 2019 in Indian Journal of Dermatology
Verified
Journal Article
Open access
PDF file
DRDeepa Rajesh
Deepa Rajesh
SNSudeep Nagaraj
Sudeep Nagaraj
PSPraveen Kumar K S
Praveen Kumar K S
AKA V Moideen Kutty
A V Moideen Kutty
SBSharath Balakrishna
Sharath Balakrishna
Background: Genetic variations associated with nonprogression of HIV infection to AIDS are enriched in psoriasis patients. HCP5 gene 335 T > G and chemokine C receptor type 5 (CCR5) gene Δ32 polymorphisms are associated with HIV nonprogression phenotype. Aim: The aim of this study was to determine the association of HCP5 gene 335 T > G (rs2395029) and CCR5 gene Δ32 (rs333) polymorphisms with psoriasis vulgaris (PV). Materials and Methods: Genotype of HCP5 gene 335 T > G and CCR5 gene Δ32 polymorphisms were determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism and allele-specific PCR methods, respectively. Results: The frequency of HCP5 gene 335 T > G SNP was ~7 times higher in PV patients than in the control group (P = 1.49 × 10–8; odds ratio [OR] = 10.2; 0.95 confidence interval [CI]: 3.9–26.8). OR for the occurrence of HCP5 335 G allele in either homozygous or heterozygous genotype in PV patients was 13.1 (0.95 CI: 4.7–36.1). The strength of association was higher with moderate-to-severe subgroup (P = 3.29 × 10–9; OR = 18.4; 0.95 CI: 6.2–54.9) than with mild subgroup (P = 2.1 × 10–4; OR = 8.3; 0.95 CI: 2.6–23.3). In addition, the strength of association was higher with Type I (P = 9.53 × 10–8; OR = 15.3; 0.95 CI: 5.1–46.5) than with Type II subgroup (P = 6.8 × 10–6; OR = 11.0; 0.95 CI: 3.6–33.9). Type I gene Δ32 polymorphism was observed neither among psoriatic nor among healthy individuals. Conclusions: Our results indicate that HCP5 gene 335 T > G polymorphism and not CCR5 gene Δ32 polymorphism is associated with the increased risk of developing PV.

1 July 2019 in Gene
Verified
Journal Article
Closed access
PSPraveen Kumar K S
Praveen Kumar K S
MAMadhuri Arcot
Madhuri Arcot
MMMunikrishna Munisamaiah
Munikrishna Munisamaiah
SBSharath Balakrishna
Sharath Balakrishna

25 April 2025 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
PSPraveen Kumar K S
Praveen Kumar K S
MJM. N. Jyothi
M. N. Jyothi
APAkila Prashant
Akila Prashant

1 February 2017 in Meta Gene
Verified
Journal Article
Closed access
KCKrishnaveni Chengalvala
Krishnaveni Chengalvala
PKPushpa Kotur
Pushpa Kotur
MSMitesh Shetty
Mitesh Shetty
PSPraveen Kumar K S
Praveen Kumar K S
JTJagadish T.V.
Jagadish T.V.
SBSharath Balakrishna
Sharath Balakrishna

19 January 2026 in Journal of Psychosexual Health
Verified
Journal Article
Open access
PSPraveen Kumar K S
Praveen Kumar K S
SJShivananda Manohar J
Shivananda Manohar J